{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:38:06Z","timestamp":1792600686367,"version":"4.5.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/cid\/ciag539","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:37:48Z","timestamp":1792597068000},"source":"Crossref","is-referenced-by-count":0,"title":["Holistic Composite Endpoints With Strategic Analyses: Toward More Informed Clinical Decision-Making for Gram-Negative Bacterial Bloodstream Infections"],"prefix":"10.1093","author":[{"given":"Scott R","family":"Evans","sequence":"first","affiliation":[{"name":"Biostatistics Center, Milken Institute School of Public Health, George Washington University , Bethesda, Maryland ,","place":["USA"]},{"name":"Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University , Washington D.C. ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4784-3227","authenticated-orcid":false,"given":"David","family":"van Duin","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of North Carolina , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"2026102111374221900_ciag539-B1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.15585\/mmwr.mm7423a2","article-title":"Notes from the field: increase in New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales\u2014New York City, 2019\u20132024","volume":"74","author":"Devinney","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026102111374221900_ciag539-B2","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.7326\/ANNALS-25-02404","article-title":"Changes in carbapenemase-producing carbapenem-resistant Enterobacterales, 2019 to 2023","volume":"178","author":"Rankin","year":"2025","journal-title":"Ann Intern Med"},{"key":"2026102111374221900_ciag539-B3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3201\/eid3206.260478","article-title":"Emergence of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae with penicillin-binding protein 3 insertions, Taiwan, 2021","volume":"32","author":"Long","year":"2026","journal-title":"Emerg Infect Dis"},{"key":"2026102111374221900_ciag539-B4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(25)00469-4","article-title":"Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial","volume":"26","author":"Paterson","year":"2026","journal-title":"Lancet Infect Dis"},{"key":"2026102111374221900_ciag539-B5","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S1473-3099(26)00008-3","article-title":"Precision diagnostics for MBLs: the true game changer in treating antimicrobial resistance","volume":"26","author":"Warecki","year":"2026","journal-title":"Lancet Infect Dis"},{"key":"2026102111374221900_ciag539-B6","doi-asserted-by":"crossref","DOI":"10.56759\/gwfz1791","volume-title":"Benefit-risk balance for medicinal products. CIOMS working group XII report","author":"Council for International Organizations of Medical Sciences (CIOMS) Working Group","year":"2025"},{"key":"2026102111374221900_ciag539-B7","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01478-25","article-title":"A patient-centric paradigm and tool for clinical research: the DOOR is open","volume":"70","author":"Hamasaki","year":"2026","journal-title":"Antimicrob Agents Chemother"},{"key":"2026102111374221900_ciag539-B8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jama.2025.12543","article-title":"Dalbavancin for treatment of staphylococcus aureus bacteremia: the DOTS randomized clinical trial","volume":"334","author":"Turner","year":"2025","journal-title":"JAMA"},{"key":"2026102111374221900_ciag539-B9","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2025.20402","article-title":"Personalized hemodynamic resuscitation targeting capillary refill time in early septic shock: the ANDROMEDA-SHOCK-2 randomized clinical trial","volume":"334","author":"ANDROMEDA-SHOCK-2 Investigators for the ANDROMEDA Research Network, Spanish Society of Anesthesiology, Reanimation and Pain Therapy (SEDAR), and Latin American Intensive Care Network (LIVEN)","year":"2025","journal-title":"JAMA"},{"key":"2026102111374221900_ciag539-B10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cmi.2016.01.023","article-title":"Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections","volume":"22","author":"Hauck","year":"2016","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag539\/72256213\/ciag539.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag539\/72256213\/ciag539.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:37:50Z","timestamp":1792597070000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/advance-article\/doi\/10.1093\/cid\/ciag539\/8965082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":10,"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag539","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"article-number":"ciag539"}}